FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:940-941 March 31, 1994 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Burrows, R. F. PubMed Citation

To the Editor: The study of Burrows and Kelton (Nov. 11 issue)¹ focuses on moderate neonatal thrombocytopenia (platelet count, 20,000 to 50,000 per cubic millimeter) and severe neonatal thrombocytopenia (<20,000 per cubic millimeter) at the time of delivery and on the relation of neonatal thrombocytopenia to maternal thrombocytopenia (<150,000 per cubic millimeter) and various maternal diseases. This is of particular interest to obstetricians, who are concerned with prenatal management and the mode of delivery^2,3.

The authors state that many of the women with idiopathic thrombocytopenic purpura had been treated with corticosteroids or intravenous immune globulin, but they give no . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.